GlassScriptPhysician profile
Reginald C W Bell
NPI 1437255072
$1,004,436.75
in general payments reported to CMS, 2019-2025
27 companies · $84K in 2025
The $84K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185K · 2020: $142K · 2021: $158K · 2022: $154K · 2023: $131K · 2024: $151K · 2025: $84K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $220K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $55K · Education: $43K · Travel and Lodging: $24K · Honoraria: $13K · Food and Beverage: $9,452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $220,164.09 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $54,929.00 |
| Education | $43,400.00 |
| Travel and Lodging | $24,458.89 |
| Honoraria | $13,200.00 |
| Food and Beverage | $9,452.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $321,897.58 | 2019-2025 | Linx Reflux Management System, Linx Reflux Management System |
| Intuitive Surgical, INC. | $309,101.72 | 2019-2025 | Da Vinci Surgical System |
| Ethicon US, LLC | $140,545.41 | 2019-2025 | Linx Reflux Management System, Linx Reflux Management System |
| Ethicon INC. | $103,234.25 | 2019-2025 | |
| Tela Bio, INC. | $57,377.64 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Davol INC. | $40,216.01 | 2019-2024 | Phasix Mesh |
| Ambu INC. | $13,319.23 | 2020-2023 | |
| Bard Peripheral Vascular, INC. | $5,982.16 | 2020 | |
| Lucid Diagnostics INC. | $5,227.68 | 2025 | |
| Medtronic, INC. | $4,446.28 | 2021-2025 | Endoflip |
| Endogastric Solutions, INC | $586.14 | 2019-2023 | Esophyx |
| Conmed Corporation | $429.13 | 2022-2024 | Airseal |
| Becton, Dickinson and Company | $413.50 | 2023-2024 | Phasix Mesh |
| Laborie Medical Technologies Corp. | $372.47 | 2024-2025 | Alphaone |
| W. L. Gore & Associates, INC. | $343.46 | 2023-2024 | Gore Enform Preperitoneal Biomaterial |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Enterra Medical, INC. | $219.98 | 2023-2024 | |
| Mauna Kea Technologies, INC. | $213.98 | 2019 | |
| Karl Storz Endoscopy-America | $189.16 | 2019 | |
| Anx Robotica Corp | $75.80 | 2022 | |
| Ethicon Endo-Surgery INC. | $51.86 | 2024 | Linx Reflux Management System |
| Covidien LP | $46.40 | 2019 | |
| Dilon Technologies, INC. | $34.35 | 2024 | Hemoblast Bellows |
| Boston Scientific Corporation | $30.50 | 2024 | Apollo Esg Nxt System |
| Acell, INC. | $27.87 | 2020 | |
| Lilly USA, LLC | $24.30 | 2024 | Omvoh |
| Lumendi LLC | $15.16 | 2019 | |
| Integra Lifesciences Corporation | $14.73 | 2023 | Integra, Omnigraft, Surgimend |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reginald Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.